ASX 200 Resources Fund

Posted on | by Leon Hinde

OZR:ASX is under Algo Engine buy conditions and we anticipate buying support to increase within the accumulation range of $10.50 to $12.50.

A sector sub-index of the S&P/ASX 200 Index, this index provides investors with exposure to the Resources sector of the Australian equity market as classified as members of the GICS® resources sector. Resources are defined as companies classified in the Energy sector (GICS® Tier 1), as well as companies classified in the Metals and Mining Industry (GICS® Tier 3).

ASX 200 Resources Fund

Posted on | by Leon Hinde

OZR:ASX is under Algo Engine buy conditions and we anticipate buying support to increase within the accumulation range of $10.50 to $12.50.

A sector sub-index of the S&P/ASX 200 Index, this index provides investors with exposure to the Resources sector of the Australian equity market as classified as members of the GICS® resources sector. Resources are defined as companies classified in the Energy sector (GICS® Tier 1), as well as companies classified in the Metals and Mining Industry (GICS® Tier 3).

September 2021: Algo Signal Performance Review.

Posted on | by Leon Hinde

The updated 5-year performance data for all Algo Engine buy and sell signals for the period ending 30 September.

Model Name: ASX S&P100 is 15.38% p/a.

Model Name: ASX ALL ETF is 14.85%.

Model Name: US S&P100 is 17.53% p/a.

The updated 5-year performance data for all Algo Engine buy and sell signals for the period ending 30 June 2021

Model Name: ASX S&P100 is 14.87% p/a.

Model Name: ASX ALL ETF is 14.9%.

Model Name: US S&P100 is 19.29% p/a.

Disclaimer: This data illustrates the simulated 5 year historical time weighted rate of return of applying our algorithm based investment model over the ASX100 & US S&P100 listed securities. Past performance is no guarantee of future returns.

iShares Global Healthcare ETF

Posted on | by Leon Hinde

iShares Global Healthcare is now under Algo Engine buy conditions and has been added to our ASX ETF model.

The fund aims to provide investors with the performance of the S&P Global 1200 Healthcare Sector IndexTM, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or small-capitalisation stocks.